Pfizer Inc

PFE

Company Profile

  • Business description

    Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

  • Contact

    66 Hudson Boulevard East
    New YorkNY10001-2192
    USA

    T: +1 212 733-2323

    E: [email protected]

    https://www.pfizer.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    88,000

Stocks News & Analysis

stocks

Unconventional wisdom: A controversial income pick

Rigid definitions of income and growth shares may be holding investors back.
stocks

How to avoid dividend disaster

Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
stocks

Why ASX miners will handily beat banks in the long-term

After a stellar run for banks, investors are wondering whether they can continue their outperformance or if a rotation into miners is imminent. There’s a good case that a switch is coming, and it may last decades, not just years.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,780.304.80-0.05%
CAC 407,973.0334.59-0.43%
DAX 4021,787.00115.42-0.53%
Dow JONES (US)44,303.40444.23-0.99%
FTSE 1008,700.5326.75-0.31%
HKSE21,133.54241.921.16%
NASDAQ19,523.40268.59-1.36%
Nikkei 22538,787.02279.51-0.72%
NZX 50 Index12,902.1957.600.45%
S&P 5006,025.9957.58-0.95%
S&P/ASX 2008,511.409.30-0.11%
SSE Composite Index3,303.6733.011.01%

Market Movers